HLA class I, II, and III polymorphism in Italian patients with sarcoidosis

Chest

Volumn 104, Issue 4, 1993, Pages 1170-1175

  Pasturenzi, L ^a   Martinetti, M ^a   Cuccia, M ^a   Cipriani, A ^a   Semenzato, G ^a,a   Luisetti, M ^a   Bulgheroni, A ^a   Donnetta, A M ^a   Peona, V ^a   Daielli, C ^a   Finco, O ^a   Tommasini, A ^a  

^a Division of Urology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B8 ANTIGEN; HLA DR3 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 3;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; HLA SYSTEM; HLA TYPING; HUMAN; HUMAN CELL; ITALY; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

EID: 0027359787     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.104.4.1170     Document Type: Article

References (35)

1. Crystal RG Bitterman PB Rennard SI Keogh BA. Interstitial lung disease of unknown causes: disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984; 310:154–66, 235-44
2. Thomas PD Hunninghake GW Current concepts of the pathogenesis of sarcoidosis Am Rev Respir Dis 135 1987 747 760
3. James DG Williams WJ Sarcoidosis and other granulomatous disorders 1985 WB Saunders Philadelphia
4. Tiwari JL Terasaki PI HLA and disease association 1985 Springer-Verlag Publishers New York 380 381
5. Abe S Yamaguchi E Makimura S Okazaki N Kunikane H Kawakami Y Association of HLA-DR with sarcoidosis: correlation with clinical course Chest 92 1987 488 490
6. Ina Y Takada K Yamamoto M Morishita M Senda Y Torii Y HLA and sarcoidosis in the Japanese Chest 95 1989 1257 1261
7. Gardner J Kennedy HG Hamblin A Jones E HLA associations in sarcoidosis: a study of two ethnic groups Thorax 39 1984 19 22
8. Smith MJ Turton CWG Mitchell DN Turner-Warwick M Morris LM Lowler SD Association of HLA-B8 with spontaneous resolution in sarcoidosis Thorax 36 1981 296 298
9. Mehra NK Bovornkitti S HLA and sarcoidosis Sarcoidosis 5 1988 87 89
10. Lenhart K Kolek V Bàrtova A HLA antigens associated with sarcoidosis Dis Markers 8 1990 23 29
11. Schoenfeld Y Isenberg D The mosaic of autoimmunity Immunol Today 10 1989 123 126
12. Blasi A Pezza A Epidemiology of sarcoidosis in Italy Sarcoidosis 6 1989 55 56
13. Reynolds HY Bronchoalveolar lavage Am Rev Respir Dis 135 1987 250 263
14. Line BR Hunninghake GW Keogh BA Jones AE Johnston GW Crystal RG Gallium-67 scanning to manage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies, and bronchoalveolar lavage Am Rev Respir Dis 123 1981 440 446
15. Bisson G Lamoureux G Bégin R Quantitative gallium 67 lung scan to assess the inflammatory activity in the pneumoconiosis Semin Nucl Med 17 1987 72 80
16. Cummiskey JM Pulmonary function testing in sarcoidosis Lieberman J Sarcoidosis 1985 Grune & Stratton Orlando, Fla 137 144
17. Lieberman J. Elevation of serum-angiotension converting enzyme (ACE) in sarcoidosis. Am J Med 1975; 59:365-72 (erratum 1976; 60:A23)
18. De Remee RA The chest roentgenology of sarcoidosis Lieberman J Sarcoidosis 1985 Grune & Stratton Orlando, Fla 117 135
19. Van Rood JJ Microlymphocytotoxicity method Ray JG Manual of tissue typing techniques 1965 National Institutes of Health Bethesda, Md 104 105
20. Semenzato G Agostini C Zamhello R Trentin L Chilosi C Pizzolo G Lung T cells in hypersensitivity pneumonitis:phenotypic and functional analyses J Immunol 137 1986 1164 1172
21. Alper CA Boenish T Watson L Genetic polymorphism in human glycine-rich beta glycoprotein J Exp Med 135 1972 68 80
22. Geserick G Abbal M Brendeu M Factor B reference typing report Complement Inflamm 7 1990 166 173
23. Awdeh ZL Alper CA Inherited structural polymorphism of the fourth component of human complement Proc Natl Acad Sci USA 77 1980 3576 3580
24. Lachmann PJ Hobart MJ Complement technology Weir DM Handbook of experimental immunology 1978 Blackwell Scientific Publications Oxford 1 23
25. Mauff G Alper CA Dawkuis R Doxiadis G Gilles GM Hauptmann Ci C4 nomenclature statement Complement Inflamm 7 1990 261 268
26. Svejgaard A Platz P Ryder LP Insulin-dependent diabetes mellitus Terasaki PI Histocompatibility testing 1980 1980 UCLA Tissue Typing Laboratory Los Angeles 638 656
27. Neville E HLA antigens and disease Mt Sinai J Med 44 1977 772 777
28. Kunikane H Abe S Tsuneta Y Nakayama T Tajima Y Misonou J Role of HLA-DR antigens in Japanese patients with sarcoidosis Am Rev Respir Dis 135 1987 688 691
29. Meyer S Tonigio MM Joint report: B8 Terasaki PI Histocompatibility testing 1980 1980 UCLA Tissue Typing Laboratory Los Angeles 356 360
30. Schwartz BD Shreffer DC Genetic influence on the immune response Parker CW Clinical immunology 1980 WB Saunders Philadelphia 49 85
31. Farid NR Graves disease Farid NR HLA in endocrine and metabolic disease 1981 Academic Press New York 85 143
32. Dasai SG Simon MR Epidemiology of sarcoidosis Lieberman J Sarcoidosis 1985 Grune & Stratton Orlando, Fla 25 37
33. Martinetti M Orecchia G Martini A Larizza D Salvaneschi L Cuccia M Is the DR5, DQW3 phenotype a predisposing factor to the pediatric form of autoimmune diseases? Int Symposium HLA in Medicine, Athens, Greece, October 22–25 1989 [abstract C16]
34. Israel HL Gottlieb JE Patrick H Steiner RM Activity assessment and treatment decision outlook Grassi C Rizzato G Pozzi E Sarcoidosis and other granulomatous disorders 1988 Excerpta Medica Amsterdam 605 617
35. Richeldi L Persichini T Ferrara GB Crystal RG Markham T Luisetti M Chronic beryllium disease association with the HLA-DP 2.1 allele Am Rev Respir Dis 145 1992 A324